Fewer than one-third of men who have sex with men were tested for Neisseria gonorrhoeae or Chlamydia trachomatis as part of HIV medical care in the United States in 2013 to 2014, and only 11.6% were tested for either sexually transmitted disease at an extragenital site.
Extragenital testing for Neisseria gonorrhoeae and Chlamydia trachomatis among HIV-infected men who have sex with men in HIV care in the United States has marginally increased in recent years but remains low.
From the *Centers for Disease Control and Prevention; and †ICF International, Atlanta, GA
Acknowledgments: The authors would like to acknowledge the staff, advisory boards, and participants of the Medical Monitoring Project: http://www.cdc.gov/hiv/statistics/systems/mmp/resources.html#StudyGroupMembers.
Sources of funding: Funding for the Medical Monitoring Project is provided by the Centers for Disease Control and Prevention.
Conflicts of interest: The authors declare no conflicts of interest.
Related presentations: Preliminary findings presented in Poster 1006 at CROI 2016; Boston, MA.
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
Correspondence: Monita R. Patel, PhD, MPH, 8 Corporate Blvd (Bldg 8), Rm 4111, Mailstop E-45, Atlanta, GA 30329. E-mail: MRPatel@cdc.gov; Heather Bradley, PhD, 8 Corporate Blvd (Bldg 8), Rm 4007, Mailstop E-46, Atlanta, GA 30329. E-mail: IYK5@cdc.gov.
Received for publication April 4, 2017, and accepted July 9, 2017.